Transaction · 0001104659-26-104739

Sherman Darren

Sherman Darren, SR, reported an open-market or private sale at Orchestra BioMed Holdings, Inc. involving 15000.000000 shares for an estimated $74100.00. Reported holdings after the transaction were 1134402.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SSR
OBIOOrchestra BioMed Holdings, Inc.
Trade date
Sep 01, 2026
Filing date
Sep 02, 2026
View on SEC Insider profile
Estimated value-$74.1kShares × reported price
Shares traded15.0k$4.94 per share
Holdings after1.13MDirect
% of reported position traded1.31%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 1,149,402 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

OBIO price since this filing

Daily closing prices, with the filing date and available return windows
OBIO · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -19.6%1w ago +9.3%1d ago +1.8%
Returns since7d +10.1%30d +20.2%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001104659-26-104739
Common Stock, par value $0.0001 per share ("Common Stock")
Transaction date
Sep 01, 2026
Filed Sep 02, 2026, 08:15 PM · 1d delay
Shares
15,000 sh
$4.94 per share
Estimated value
-$74.1k
Computed from shares × price
Holdings after
1,134,402 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership 10b5-1 Detected
Filing-only score

0 points

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 1

    Filing reported within two business days of the transaction.
  • tenb5_1_detected-10 points

    is_10b5_1 = true

    Stored filing content includes detected 10b5-1 language.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

See Remarks

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 18, 2025.

  2. F2

    The price reported is a weighted average price. These shares were disposed in multiple transactions at prices ranging from $4.88 to $5.06. The reporting person undertakes to provide to the Issuer, any…

  3. F3

    The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purpo…

Original filing · 0001104659-26-104739
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

OBIO